HDAC9 and leukemia: Given that curaxin CBL0137 inhibits KMT2A-r leukemia cell growth by rapidly inducing apoptosis (5), we next determined whether HDAC inhibition boosted CBL0137-induced apoptosis by measuring the level of annexin V+ cells.